Skip to main content

Lupus clinical trials at UCSF

3 in progress, 2 open to eligible people

Lupus is a disease that affects the immune system. UCSF has trials recruiting people with Lupus Nephritis, a kidney complication. One trial is testing a drug called VIB4920 with mycophenolate mofetil and prednisone, and another is testing a drug called obinutuzumab in adolescents with biopsy-confirmed proliferative Lupus Nephritis.

Showing trials for

Our lead scientists for Lupus research studies include .

Last updated: